An already-approved IV drug significantly reduces the symptoms of lupus, a new clinical trial showed. More than three-quarters of lupus patients taking obinutuzumab (Gazvya) had a significant ...

Autoimmune disease hair loss can happen with alopecia areata, lupus, thyroid diseases, rheumatoid arthritis, Crohn’s disease, and scalp psoriasis. Each disease has different effects, ...

Nipocalimab has been granted U.S. Food and Drug Administration Fast Track designation as a potential treatment for adults with systemic lupus erythematosus (SLE). Fast Track designation is designed to ...

New analysis of Gazyva® shows the drug significantly reduces disease activity in adults with systemic lupus erythematosus.

March is National Kidney Month, a time to shine a light on the thousands of individuals whose lives are deeply affected by ...

Patients with lupus nephritis complicated by thrombotic microangiopathy tend to have high death risk and poor renal outcomes. They need vital and effective therapies.

Dr. Nishtha Sareen, medical director of the Ascension Saint Thomas Women's Heart Program, offered free heart screenings to 250 women in 250 days in 2025. One of those screenings revealed that a woman, ...

Johnson & Johnson’s (J&J) nipocalimab, a potential immunoselective investigational treatment for adults with systemic lupus ...

A “living drug” was developed as a cancer treatment. Now it is showing promise for conditions, such as lupus and multiple sclerosis, that have long been considered incurable.

A woman in her 30s presented with generalised swelling and a right occipital–temporal headache. Examination showed grade 4 papilloedema, and magnetic resonance venography revealed thrombosis of the ...

In the United States, SLE remains associated with substantial mortality, particularly among Non-Hispanic Black women.

Normally, your immune system fights off disease and protects your body from infection. However, when you have an autoimmune disease, your immune system mistakenly attacks healthy cells, tissues and ...